News Headlines Article

U.S. leads on cancer spending, survival gains: study
Modern Healthcare

Compared with 10 European countries, the U.S. spends more to treat cancer patients, but the U.S. has seen greater gains in survival for 11 of 13 cancers during a 16-year period, a new study shows.

The research, published in the journal Health Affairs, estimated the value of the U.S. survival gains totaled $598 billion, or $43 billion annually. That is after subtracting higher U.S. spending, the authors said.